Literature DB >> 31729463

Electrostatic complementarity of B-cell receptor CDR3s and TP53-mutant amino acids in breast cancer is associated with increased disease-free survival rates.

Juan F Arturo1, Boris I Chobrutskiy1, Michelle Yeagley1, Dhruv N Patel1, Shayan Falasiri1, Jay S Patel1, George Blanck2,3.   

Abstract

Entities:  

Year:  2019        PMID： 31729463      PMCID： PMC7331692          DOI： 10.1038/s41423-019-0328-8

Source DB:  PubMed          Journal:  Cell Mol Immunol        ISSN： 1672-7681            Impact factor:   11.530


× No keyword cloud information.
  4 in total

1.  Immune receptor CDR3 chemical features that preserve sequence information are highly efficient in reflecting survival distinctions: A pan-cancer analysis.

Authors:  Brooke E Mcbreairty; Boris I Chobrutskiy; Andrea Chobrutskiy; Etienne C Gozlan; Michael J Diaz; George Blanck
Journal:  Biomed Rep       Date:  2022-06-09

2.  Delineation of a T-cell receptor CDR3-cancer mutanome aromaticity factor, assessable via blood samples, that facilitates the establishment of survival distinctions in bladder cancer.

Authors:  Jacqueline Wahura Waweru; Kennedy Wanjau Mwangi; Vayda R Barker; Etienne C Gozlan; Michelle Yeagley; George Blanck; Francis W Makokha
Journal:  J Cancer Res Clin Oncol       Date:  2022-09-13       Impact factor: 4.322

3.  Systemic Adaptive Immune Parameters Associated with Neuroblastoma Outcomes: the Significance of Gamma-Delta T Cells.

Authors:  Etienne C Gozlan; Boris I Chobrutskiy; Saif Zaman; Michelle Yeagley; George Blanck
Journal:  J Mol Neurosci       Date:  2021-03-05       Impact factor: 3.444

4.  Identification of the potential roles of ring finger protein 8 in TP53-mutant breast cancer.

Authors:  Feng Zhao; Peibin Wang; Yan Guo; Qi Lu; Xu Kong; Dongwei Su; Hengyu Li; Guoping Liu; Chaoqian Liu
Journal:  Oncol Lett       Date:  2020-11-17       Impact factor: 2.967
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.